$ZS

Schlossman Robert sold $18K of ZS

Schlossman Robert (Chief Legal Officer) sold 122 shares of Zscaler, Inc. (ZS) at $150.00 on 2026-07-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Schlossman Robert
Published Jul 7, 2026, 10:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 7, 2026, 10:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ZS
Neutral
high confidence
Mentioned
$ZS
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ZSNeutralLow
01

Why it matters

The disclosed sale is pre-arranged under a Rule 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

02

Market read

Traders may note the filing for sentiment/flow context, but the small dollar amount and 10b5-1 structure make it unlikely to drive a material repricing.

03

What to watch

The article provides only one sale; without context on prior insider activity or total planned volume, signal strength is limited.

Relevance 2/10Novelty 3/10Timing: Filed on 2026-07-07 after-hours; relevant for next-session sentiment/positioning.

Background

This is an SEC Form 4 insider transaction disclosure for Zscaler, Inc., reported by the Chief Legal Officer.

Company-level read

Ticker impact

$ZSNeutralHigh confidence
Context

Zscaler insider Chief Legal Officer Robert Schlossman sold 122 shares at $150/share under a 10b5-1 plan, totaling $18,300.

Expected impact

Low near-term impact; any reaction is likely limited to sentiment/technical positioning rather than fundamentals.

Evidence & confidence

The filing is a Form 4 insider transaction and explicitly states a pre-arranged 10b5-1 plan; the disclosed value ($18.3k) is small versus typical market cap moves.

Market effects

No sector read-through; this is a single-company, small-value insider sale.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with broader risk management or diversification, which some traders may still fade.

Key entities

  • Zscaler, Inc.

    Subject of the Form 4 insider transaction; insider sale disclosed under a 10b5-1 plan.

  • Robert Schlossman

    Chief Legal Officer who sold 122 shares at $150/share.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ZSMed

Zscaler (ZS) Sets $8B ARR Goal by FY2031 Amid Mixed Analyst View

Zscaler (ZS) aims to reach $8B in annual recurring revenue by FY2031, a 2.4x increase from current revenue. Analysts' views are mixed, with Morgan Stanley lowering its price target to $185 and UBS raising it to $250. The company's P/S ratio is 10.14x, below its historical median of 18.9x, reflecting market skepticism about growth and profitability.

$ZSMed

ZSCALER (ZS) Maintained by JP Morgan -- Price Target Raised to $

JP Morgan maintained an Overweight rating on Zscaler (ZS) and raised its price target from $215 to $245. The company's GF Value™ suggests it is 28.2% undervalued, with a GF Score™ of 76/100. Insider selling totaled $6.4M over the past three months. Zscaler operates in cloud-native cybersecurity, serving large enterprises and government agencies.

$ZSMed

ZS Maintained by Barclays -- Price Target Raised to $225

Barclays maintained an Overweight rating for Zscaler (ZS) and raised its price target to $225 from $220. GuruFocus values ZS at $296.22, suggesting a 29.1% undervaluation at its current price of $210.08. The company has a GF Score of 76/100, indicating strong growth and valuation but low profitability. Insider selling totaled $6.4M in the last 3 months.